Why are you reporting this TALK?
ONL Therapeutics – Xelafaslatide (GALAXY)
Jay ChhablaniVisit
ophthalmologytimes.com
to learn moreNovember 18, 2025
7 min
Channels
DiscoveryCardiologyCOVIDDermatologyEndocrinologyGastroenterologyHematologyHepatologyNephrologyNeurologyOncologyOphthalmologyEvery DayAMDDry Eye DiseaseEyeCan: A Canadian Lens on OphthalmologyVISIONS 2024ARVO 2024AAO 2023WIO 2022
Primary CarePulmonologyRheumatologyUrologyDescription
ONL Therapeutics – Xelafaslatide (GALAXY)